Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-013199
Filing Date
2025-03-17
Accepted
2025-03-17 17:17:28
Documents
1
Period of Report
2025-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1742246240.html 4  
1 FORM 4 wk-form4_1742246240.xml 4 5494
  Complete submission text file 0001628280-25-013199.txt   7067
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Koenig Sheldon L. (Reporting) CIK: 0001766524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 25745632